PPAR Ligands for Cancer Chemoprevention
Peroxisome proliferators-activated receptors (PPARs) that are members of the nuclear receptor superfamily have three different isoforms: PPARα, PPARδ, and PPARγ. PPARs are ligand-activated transcription factors, and they are implicated in tumor progression, differentiation, and apoptosis. Activation...
Saved in:
| Main Authors: | Yumiko Yasui, Mihye Kim, Takuji Tanaka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2008-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2008/548919 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPARγ Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study
by: Hirokazu Takahashi, et al.
Published: (2010-01-01) -
Development of an Inflammation-Associated Colorectal Cancer Model and Its Application for Research on Carcinogenesis and Chemoprevention
by: Takuji Tanaka
Published: (2012-01-01) -
Clinical Use of PPARγ Ligands in Cancer
by: Jennifer L. Hatton, et al.
Published: (2008-01-01) -
Nutraceuticals as Ligands of PPARγ
by: Meera Penumetcha, et al.
Published: (2012-01-01) -
Chemoprevention of Gastric Cancer: Metformin
by: Young-Il Kim, et al.
Published: (2017-12-01)